Egypt - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Egypt Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 25.2% year on year. In 2019, the country was ranked number 92 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 264 Cases. Egypt is overtaken by Ghana, which was ranked number 91 with 266 Cases and is followed by Lesotho with 259 Cases. India topped the ranking with 66,255 Cases in 2019, a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 264.00 |
| 2018 | 142.00 |
| 2017 | 152.00 |
| 2016 | 174.00 |
| 2015 | 210.00 |
How does Egypt rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 91 |
#91
Ghana
|
266 | 2019 | +15.2 % | +23.4 % | View data | |
| 92 |
#92
Egypt
|
264 | 2019 | +85.9 % | +25.1 % | View data | |
| 95 |
#95
Turkey
|
256 | 2019 | -0.4 % | -6.0 % | View data | |